3692:HKG
Hansoh Pharmaceutical Group Company Ltd
31,74 HK$
arrow_upward
+1,15%(+0,36) 1K
16-okt, 16:08:14 (GMT+8) · HKD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto3692 tikeri uchun statistika yaratilmoqda...
Ochish
31,72 HK$
Yuqori
32,44 HK$
Past
31,52 HK$
Bozor kapitali
192,48 mlrd
Oʻrtacha hajm
8,58 mln
Hajmi
10,50 mln
Dividend
1,53%
Choraklik dividendlar
0,12 HK$
Eks-dividend sanasi
22-sen, 2026
P/E koeffitsiyenti
24,51
52 haftalik eng yuqori
44,22 HK$
52 haftalik eng past
28,06 HK$
Aksiya boʻyicha daromad
1,30 HK$
Xodimlar soni
10 ming
Ochish
31,72 HK$
Yuqori
32,44 HK$
Past
31,52 HK$
Bozor kapitali
192,48 mlrd
Oʻrtacha hajm
8,58 mln
Hajmi
10,50 mln
Dividend
1,53%
Choraklik dividendlar
0,12 HK$
Eks-dividend sanasi
22-sen, 2026
P/E koeffitsiyenti
24,51
52 haftalik eng yuqori
44,22 HK$
52 haftalik eng past
28,06 HK$
Aksiya boʻyicha daromad
1,30 HK$
Xodimlar soni
10 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
16 soat oldin
Hansoh Pharma stock gets HKD 47.82 consensus target
Simply Wall Street
·
16 soat oldin
Could EMA Review Alter The Investment Case For Hansoh Pharma Stock (SEHK:3692)?
Profil
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Hansoh Pharmaceutical Group Company Ltd haqida